Some froth, but no bubble in Chinese stocks

The Shanghai Composite index has soared in recent months, but investors can expect more growth to come.

We've often pointed out that stockmarkets don't always reflect the economic fundamentals. China's is a classic example. Annual growth is running at its slowest pace since 1990. But stocks have rocketed. In the last three months of 2014, the Shanghai Composite index leapt by 37%. This quarter it has gained another 6%, to hit a six-year high.

As with most markets right now, the promise of easier money, along with past liquidity injections, has underpinned the feel-good factor. Last week, after a nasty run of data suggested that growth could well undershoot the official 7% target for this year, the government stepped in to pat worried investors on the hand. It promised to keep growth in "a reasonable range" and step up stimulus efforts if the downturn hurt employment and incomes.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.